NUCLEIC ACIDS RESEARCH
Subject Area | Rank | Percentile |
---|---|---|
Category: Biochemistry, Genetics and Molecular Biology Subcategory: Genetics |
6 / 347 |
APC | APC Waiver | Other Charges |
---|---|---|
Yes: Check details ( USD3802; ) | Yes: Check details | No |
Quartiles By JIF | Collection | Quartile | Rank | Percentage |
Category: BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | 6/313 |
|
Quartiles By JCI | Collection | Quartile | Rank | Percentage |
Category: BIOCHEMISTRY & MOLECULAR BIOLOGY | SCIE | Q1 | 6/313 |
|
Journal Title | h-index | CiteScore |
---|---|---|
NATURE MEDICINE | 497 | 100.90 |
CELL | 705 | 110.00 |
Molecular Cancer | 103 | 54.90 |
Molecular Plant | 85 | 37.60 |
Molecular Cell | 356 | 26.00 |
PROGRESS IN LIPID RESEARCH | 132 | 24.50 |
TRENDS IN MICROBIOLOGY | 172 | 25.30 |
CELL DEATH AND DIFFERENTIATION | 193 | 24.70 |
Nature Chemical Biology | 182 | 23.90 |
TRENDS IN MOLECULAR MEDICINE | 160 | 24.60 |
Select your rating and start your review of NUCLEIC ACIDS RESEARCH
2025-03-18
2.11 submit
2.15 peer review
The email mentioned that the first review would take about three weeks, but it has been a month and still no response. I couldn't find a timeline for how long the first review usually takes online. Hopefully, luck is on my side!
2025-01-22
During my PhD, my proudest achievement was published in NAR. I felt extremely anxious during the two months of submission, often checking the website to see others' experiences. Now, I will share my specific timeline.
2024.11.24 Submitted
2024.12.05 in peer review
2024.12.19 Received reviewer comments from two reviewers and the editor. The first reviewer seemed less enthusiastic but provided valuable feedback, while the second reviewer highly appreciated our results and raised many insightful questions, feeling as if they were involved in the project. The editor leaned towards the second reviewer's opinion, allowing a revision period of seven months.
2025.01.13 Resubmitted the manuscript. Despite the lengthy revision period, only a few experiments needed to be added. The focus was on addressing the reviewers' questions in the paper and resubmitting before the new year.
2025.01.16 in editorial review
2025.01.22 Paper accepted. The article was accepted without being sent back to the reviewers, and the editor accepted it directly.
This was my first experience with a reputable journal, and my mentor taught me to respect all reviewers' opinions and respond politely and attentively, avoiding unnecessary words and keeping the responses concise. Our lab has already published three articles in NAR, with a total turnaround time of less than two months and a review period of about two weeks. Some hot topics or competitive directions may have a faster review process.
2024-11-21
Submission on October 12, 2024
Under review in the first round on October 26, 2024
2024-11-19
Now some primary schools in the country (some first-tier and second-tier) only consider the district rankings, which can be classified as secondary publications based on the level of NC... After NAR was classified as second-tier, it is not as good as those first-tier journals.
2024-10-31
You said that the database is corrupt, but domestic MP, imeta, and SB don't do things so blatantly. To put it bluntly, this magazine publisher has less influence, so it doesn't have as much vested interest in domestic affairs.
2024-09-27
I can't understand why NAR, such a classic journal, has been listed as a double second-zone journal by the Chinese Academy of Sciences for nearly three years, while many domestic journals can easily be listed as first-zone journals.
2024-06-08
Please select.
2024-05-15
Domestic partition drives people crazy. Everyone is spinning around the baton, spinning their hats. No one is seriously engaging in scientific research
2024-05-15
elife is also good, I have published an article there. Its positioning should be on par with PC and NAR, but the culture within the community is quite serious
2024-05-15
NAR and PLANT Cell are currently considered to be the top two journals in many foreign botanical laboratories. NAR is a classic old journal with a good reputation, influence, and rigor. It also has a high impact factor. Cell reports is far behind. I don't understand why NAR was ranked in the second quartile